BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
Lenalidomide is used to treat various types of cancers.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Subscribe To Our Newsletter & Stay Updated